Proprietary Medical Device Data Helps Businesses Adapt in the Shifting Healthcare Landscape, Post-Affordable Care Act
FARMINGTON, Conn., Feb. 14, 2013 /PRNewswire-iReach/ — Global Information (GII), in partnership with Millennium Research Group (MRG), the world’s largest provider of medical device market research, are pleased to announce immediate availability of new, actionable analytics and insightful data for experts, from experts. With over 10 years of experience helping medtech companies gain ground, MRG collaborates with industry experts, medical professionals and healthcare executives to provide clients with the benefits of its specialized market expertise through syndicated reports. Based on an expansive library of in-house data including proprietary market databases and industry interviews, the reports provide insights and opinions generated from over 30,000 end-users each year, in-depth top-down and bottom-up analysis, and also includes presentation-ready tables and graphics.
Together, GII and MRG provide a trusted platform for medical device companies to gain unparalleled access to the healthcare data they need against a fluctuating regulatory environment shrouded in uncertainty. As the US government implements the Affordable Care Act and tries to tighten its belt on healthcare spending, the focus on choosing products and procedures will shift to those that balance cost and clinical outcomes most effectively. How will the healthcare system balance cost-minimizing initiatives with a growing population of people demanding more medical devices? Achieving the right balance between cost minimization and value-added innovation will be critical in the next decade.
Below are highlights from just three of the hundreds of medical device market research reports available from MRG and GII, focusing on key device markets.
US Markets for Orthopedic Biomaterials 2013
A resurgence in the bone graft substitute (BGS) segment will help the US orthopedic biomaterial market to grow to nearly $3.7 billion by 2017. While the BGS segment is still suffering from a drop in sales of Medtronic’s INFUSE product, INFUSE remains the highest-revenue product in this segment. However, the growth factor market will make a comeback, which be drive in part by increasing uptake of advanced biologics’ OsteoAMP growth factor product, along with Wright Medical Technology’s Augment and Cerapedics’ i-Factor products. Meanwhile, cost containment measures at hospitals will curb this resurgence and many surgeons will opt to use lesser-expensive alternatives, including orthopedic stem cell products and second-generation synthetics.
The fastest growing segment in the US orthopedic biomaterials market will be hyaluronic acid (HA) viscosupplementation due to a growing trend in patients opting for more convenient, but more expensive, single-injection HA treatments.
This report provides unit, average selling price and revenue information, along with market drivers and limiters and the competitive landscape for BGS, hyaluronic acid viscosupplementation, machined bone interbody devices and cell concentration systems in the U.S.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mrg225459-us-markets-orthopedic-biomaterials-2012.html
US Markets for Diabetes Care Devices 2013
The continued increase in the prevalence of diabetes, combined with an expansion of insurance coverage as a consequence of healthcare reform, will cause the United States diabetes care device market to grow to nearly $16 billion by 2017. The market segments for continuous glucose monitoring (CGM) devices, insulin pumps and pens will exhibit even stronger growth, driven by innovation and an increasing uptake by diabetes patients.
Three companies, Dexcom, Medtronic and Abbott Laboratories currently dominate the dynamic CGM market, and have launched several iterations of their products, but new entrants are likely in the near future, given the available opportunities for advanced products. Some of the largest competitors in the diabetes care device market, including Sanofi, Novo Nordisk and Eli Lilly, manufacture and sell insulin, which gives them a competitive advantage.
This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mrg259781-us-markets-diabetes-care-devices.html
US Markets for Minimally Invasive Spine Technologies 2013
The minimally invasive spine technology market has recognized strong growth due to an increasing focus on this segment by manufacturers and physicians and the continued introduction of new devices. Innovations that enhance patient outcomes and enhance ease-of-use for physicians will give competitors a significant advantage through 2017.
Meanwhile, increasing competition has led to declines in average selling prices, which favors companies with substantial manufacturing capabilities that can benefit from economies of scale. Larger companies with broad product portfolios that include other spine and orthopedic products will also be at an advantage because they can offer bundled packages sold at a discount.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mrg142029-us-mini-invasi-spine.html
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/wild243599-nutrition-vitamins-partnering-2007-2012.html
For more market research highlights, technical research news and industry updates, please visit http://www.giiresearch.com/press/
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.